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Resident stem/progenitor cells in the lung are important for tissue homeostasis and repair. However, a progenitor
population for alveolar type II (ATII) cells in adult human lungs has not been identified. The aim of this study is to isolate
progenitor cells from adult human lungs with the ability to differentiate into ATII cells. We isolated colony-forming cells
that had the capability for self-renewal and the potential to generate ATII cells in vitro. These undifferentiated progenitor
cells expressed surface markers of mesenchymal stem cells (MSCs) and surfactant proteins associated with ATII cells, such
as CD90 and pro-surfactant protein-C (pro-SP-C), respectively. Microarray analyses indicated that transcripts associated
with lung development were enriched in the pro-SP-C
þ/CD90
þ cells compared with bone marrow-MSCs. Furthermore,
pathological evaluation indicated that pro-SP-C and CD90 double-positive cells were present within alveolar walls in
normal lungs, and significantly increased in ATII cell hyperplasias contributing to alveolar epithelial repair in damaged
lungs. Our findings demonstrated that adult human lungs contain a progenitor population for ATII cells. This study
is a first step toward better understanding of stem cell biology in adult human lung alveoli.
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Resident stem/progenitor cells in the lung have important
roles in tissue homeostasis and repair. The adult lung consists
of four major, biologically distinct components including,
the trachea, bronchi, bronchioles and alveoli, and each
component has a specific stem/progenitor population.
1–5 The
alveoli are specialized terminal structures of distal airways for
gas exchange. The gaseous alveolar surface is lined by two
types of epithelial cells: alveolar type I (ATI) and alveolar type
II (ATII) cells. ATI cells are broad- and flat-shaped cells,
which cover 95% of the alveolar surface. ATII cells are cu-
boidal shaped and produce alveolar surfactants. ATI cells are
more sensitive to injuries than ATII cells.
6 When ATI cells are
damaged, adjacent ATII cells are stimulated to proliferate
and transdifferentiate into ATI cells.
7–11 Therefore, ATII cells
have long been considered to serve as progenitor cells in the
alveoli.
7–11
Recent studies on rodent models have identified stem/
progenitor populations for alveolar epithelial cells, and have
revealed that the stem/progenitor populations have impor-
tant roles in lung repair and carcinogenesis.
12–18 In distal
lungs of adult human, to our knowledge, only two stem cell
populations were isolated.
19,20 The first report showed that
lung resident mesenchymal stem cells (MSCs) isolated from
bronchoalveolar lavage fluid collected from lung transplant
patients have the self-renewal ability and the differentiation
capability into a mesodermal lineage.
19 The second report
demonstrated that MSCs isolated from distal lung tissues
have the potential to express aquaporin 5 (AQP5; a marker
for ATI cells) under the specific culture condition.
20 How-
ever, a progenitor population that can differentiate into ATII
cells has not been isolated from adult human lungs. There-
fore, studies regarding roles of stem/progenitor cells in
intractable pulmonary diseases, such as pulmonary fibrosis
and lung emphysema, have been limited.
The aim of this study was to isolate progenitor cells from
adult human lungs that can differentiate into ATII cells.
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of surfactant proteins associated with ATII cells. We found
that these cells had the ability to self-renew and the capability
to generate ATII cells in vitro. Microarray analyses indicated
that genes encoding transcription factors important for lung
development were enriched in this progenitor population,
compared with bone marrow-MSCs (BM-MSCs). In addi-
tion, pathological evaluation showed that this progenitor
population existed in normal alveoli, and significantly in-
creased within ATII cell hyperplasia, which is recognized as
regenerative epithelium in damaged lungs.
10,11
MATERIALS AND METHODS
Patients and Preparation of Tissue Specimens
For cell isolation, human lung tissues were obtained from
patients who underwent lung resection at the Department of
Thoracic Surgery at Tohoku University Hospital and the
Department of Thoracic Surgery at the Ishinomaki Red Cross
Hospital. Patients’ characteristics are summarized in Table 1.
In patients with lung tumors, lung tissues were obtained
from sites away from the tumors. In patients with pulmonary
fibrosis, fibrotic lungs and distant normal lungs were used.
In patients with pneumothorax, normal lung tissues around
the bulla were analyzed. Half of the tissues were used for cell
isolation as described below, and remaining tissues were
utilized for histological evaluations. The remaining tissues
were inflated with formalin or a mixture of Tissue-Tek OCT
compound (Sakura, Zoeterwounde, The Netherlands) and
PBS, and embedded in paraffin or OCT compound. This
study was approved by the Ethics Committee at Tohoku
University School of Medicine and the Ishinomaki Red Cross
Hospital. All subjects gave informed consent.
Separation of Human Lung Cells and Cell Culture
Human lung cells were isolated as previously described with
some modifications.
12 We separated distal lung tissues within
3cm from pleura. After pleura were separated bluntly, lung
specimens were cut into 1 1 1cm
3 pieces. The samples
were inflated with dispase II (Roche Applied Science, Man-
nheim, Germany; final concentration, 2.0U/ml) and placed
in conical tubes containing dispase II, collagenase/dispase
(Roche Applied Science; final concentration, 1mg/ml)
and DNase I (Sigma-Aldrich, St Louis, MO, USA; final
concentration, 0.1mg/ml), and incubated for 90–120min at
371C with shaking. Enzymatically digested samples were
minced with scissors, passed through needles, and filtered
through a 100-mm mesh (BD Biosciences, San Jose, CA,
USA). After treatment with red blood cell lysis buffer
(Roche Applied Science), the cells were filtered through a
40-mm mesh (BD Biosciences) and resuspended in
DMEM (Invitrogen, Carlsbad, CA, USA) containing 10%
FBS (Invitrogen), 1% amino acids solution (Invitrogen),
100units/ml penicillin, 100mg/ml streptomycin (antibiotics;
Sigma-Aldrich), and 2.5mg/ml amphotericin B.
Hematopoietic cells were depleted from the lung cell
suspension using the autoMACS Separator with anti-human
CD45 antibody-coated micro-beads according to the manu-
facturer’s instructions (Miltenyi Biotec, Bergisch Gladbach,
Germany). Sorted CD45
  lung cells were divided for primary
culture, flow cytometric analysis, or preservation in liquid
nitrogen.
To isolate a putative progenitor population, CD45
– lung
cells were seeded at a density of 1–5 10
4cells/cm
2 on mi-
totically inactivated mouse embryonic fibroblasts (feeders)
with DMEM/10%FBS/1% amino acids solution/antibiotics in
a humidified 5% CO2 incubator at 371C. Mouse embryonic
fibroblasts were isolated from C57BL/6 pregnant mice at 13
or 14 days of gestation. Mitotic inactivation was performed
using mitomycin-C (Sigma-Aldrich). In CD45
– lung cell
cultures, amphotericin B (2.5mg/ml) was added during
the first week. For patient samples, subconfluent cells
were trypsinized and plated on feeders on a 100-mm dish
(TPP, Trasadingen, Switzerland) with DMEM/10%FBS/1%
amino acid solution/antibiotics (passage 1). From passage 2,
subconfluent cells were passaged with feeder-conditioned
medium (FCM). FCM was defined as a mixture of DMEM/
10% FBS/1% amino acids solution/antibiotics with super-
natant collected from only feeder cultures, in the proportion
of one part to one.
Human MSCs were purchased and cultured with
TheraPEAK chemically defined MSC growth medium
(Lonza Walkersiville, Walkersiville, MD, USA).
Flow Cytometry
Cell-surface and cytoplasmic antigens were examined by
flow cytometry with the FACSCalibur flow cytometer
(BD Biosciences). The data were analyzed by CellQuest
Pro (BD Biosciences). We used the following antibodies:
Table 1 Characteristics of patients (n¼11)
a
Age, years 58.4±20.2 (20–80)
Gender, male/female 8/3
Height, cm 163.5±9.3 (150–177)
Weight, kg 60.4±13.4 (41–86.4)
Pack-years 34.2±37.5 (0–95)
Indication for lung resection (number of the patients)
Lung cancer 7
b
Open lung biopsy 3
c
Pneumothorax 1
aData are expressed as mean±s.d. (range).
bTwo patients had chronic obstructive pulmonary disease (COPD). COPD
severity was Stage I (mild) in both patients, based on spirometric classification
by Global Initiative for COPD (GOLD).
cPathological examination showed that a patient had usual idiopathic
pneumonia and two patients had organizing pneumonia.
Adult human lung progenitor cells
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erythrin (PE)-anti-human E-cadherin (Biolegend, San Diego,
CA, USA), FITC-anti-human CD31, PE-anti-human CD73,
allophycocyanin (APC) anti-human CD90, PE-anti-human
c-kit (BD Biosciences), PE-anti-human CD133/1 (Miltenyi
Biotec), FITC-anti-human CD34 (IMMUNOTECH, Praha,
Czech) and PE-anti-human vascular endothelial growth fac-
tor receptor 2 (BD Biosciences). To stain E-cadherin, cultured
cells were harvested using 1mM EDTA. Isotype-matched
antibodies were used as negative controls. To stain in-
tracellular antigens, IntraPrep (Beckman Coulter, Fullerton,
CA, USA) was used for fixation and permeabilization
according to the manufacturer’s instructions. Rabbit anti-
human pro-surfactant protein-C (pro-SP-C) polyclonal an-
tibody (Millipore Corporation, Billerica, MA, USA) was used
as the primary antibody. PE-labeled goat anti-rabbit IgG
(Molecular Probes, Carlsbad, CA, USA) or FITC-labeled goat
anti-rabbit IgG (Vector, Burlingame, CA, USA) were used for
the secondary antibodies. Normal rabbit serum (Sigma-
Aldrich) and PE or FITC-labeled goat anti-rabbit IgG
(Molecular Probes or Vector, respectively) were applied for
negative control of pro-SP-C staining. We used primary
CD45
  lung cells as positive and negative controls for the
staining of pro-SP-C and CD90. In addition, we optimized
the concentration of rabbit anti-human pro-SP-C antibody
and normal rabbit serum using primary CD45
  lung cells in
the flow cytometric analysis.
Immunofluorescence Staining in Cultured Cells
The cultured cells or the cytospun cells were fixed with
acetone for 10min at  201C in staining for CD90. For
staining of antigens other than CD90, cells were fixed with
4% paraformaldehyde for 10min at 41C. Samples were
blocked and permeabilized with 0.1% Triton X/10% goat
serum/1% BSA/PBS for 30min at room temperature. The
cells were incubated with primary antibodies as follows:
mouse anti-human surfactant protein-A (SP-A) monoclonal
antibody (1:1000, Abcam, Cambridge, MA, USA), rabbit
anti-human pro-SP-C polyclonal antibody (1:1000, Milli-
pore), mouse anti-human surfactant protein-D (SP-D)
monoclonal antibody (1:20, Abcam), mouse anti-human
vimentin monoclonal antibody (1:100, Dako, Glostrup,
Denmark), mouse anti-human CD90 monoclonal antibody
(1:50, BD Biosciences) overnight at 41C. Alexa Fluor 546-
conjugated goat anti-rabbit IgG and Alexa Fluor 488- or 647-
conjugated goat anti-mouse IgG (1:100, Molecular Probes)
were used as secondary antibodies. After mounting of sec-
tions and staining of nuclei using ProLong Gold antifade
reagent with DAPI (40,6-diamidino-2-phenylindole) (Mole-
cular Probes), samples were observed via fluorescent
microscopy (Leica Microsystems, Tokyo, Japan). To avoid
false-positive fluorescence image development, the capture
condition (exposure time: 200ms) was fixed, and g, contrast,
or brightness of the images was not changed during the
imaging processes.
Limiting Dilution Analysis and Single-Cell Sorting
The cells that we obtained using feeder culture were harvested
at passage 4, and then 1, 10, or 100cells/well were sorted and
cultured on 96-well plates (Corning Incorporated, Corning,
NY, USA). After 14 days, the number of wells without
colonies was counted. To determine the frequency of clono-
genic cells in each population, the cell number was deter-
mined from the point at which the regression line crossed
37%, which correlates with each colony provided by a single
cell.
12,21 Regression analysis was performed with GraphPad
Prism Version 5.0b (GraphPad Software, San Diego, CA,
USA). To isolate and expand clonogenic cells, single cells that
were sorted into 96-well plates (Corning Incorporated)
by FACSAria II cell sorter (BD Biosciences) were cultured
with FCM.
Total RNA Isolation and RT–PCR
Total RNA was extracted using TRIzol (Invitrogen). For
microarray, the total RNA was cleaned up by miRNeasy Mini
kit (QIAGEN, Tokyo, Japan). The isolated RNA was assessed
for quantity and quality via UV spectrophotometry using a
ND-100 spectrophotometer (Nano Drop Technologies,
Rockland, DE, USA). cDNA was synthesized with QuantiTect
Reverse Transcription Kit (QIAGEN) from 1mg of the total
RNA. One out of 20 of the single-strand cDNA products was
used for each PCR reaction. Semiquantitative RT–PCR was
performed with Takara Ex Taq Hot Start Version (Takara Bio,
Shiga, Japan). Cycling conditions were as follows: (i) 5min at
941C; (ii) 30s at 941C; (iii) 30s at each annealing tempera-
ture; (iv) 30s at 721C; and (v) 7min at 721C. The steps (ii–iv)
were repeated in each cycle number. Human-specific
intron-spanning primer pairs were used. The primer se-
quences, annealing temperatures, cycle numbers, and PCR
product sizes are shown in Table 2. The PCR products were
visualized with ethidium bromide after electrophoresis
on 2% agarose gel.
Assay for Mesenchymal Differentiation
Induction of adipogenic, osteogenic, and chondrogenic
differentiation was performed with the Human Mesenchymal
Stem Cell Functional Identification Kit (R&D systems,
Minneapolis, MN, USA). For evaluating adipogenic differ-
entiation, fatty acid binding protein 4 (FABP4) was analyzed
by immunofluorescence staining. In addition, oil red O
staining was performed to detect the accumulation of lipids.
For osteogenic differentiation, osteocalcin was evaluated by
immunofluorescence, and alizarin S staining was performed
to show calcium deposition. To demonstrate chondrogenic
differentiation, the expression of aggrecan was examined by
immunofluorescence staining. All primary antibodies were
supplied with the Human Mesenchymal Stem Cell Functional
Identification Kit. Alexa Fluor 546-conjugated donkey
anti-goat IgG antibody and Alexa Fluor 488-conjugated goat
anti-mouse IgG antibody (Molecular Probes) were used as
secondary antibodies.
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To evaluate gene expression profiles, total RNA was extracted
and cleaned up from three batches of our isolated cells at
passage 4 as previously described in the Materials and
Methods section. RNA targets were prepared according to the
manufacturer’s protocol using GeneChip 30 IVT Express Kit
(Affymetrix, Santa Clara, CA, USA). The total RNA (100ng)
was converted into double-stranded cDNA template for
transcription. In vitro transcription synthesized amplified
RNA (aRNA) and incorporated a biotin-conjugated nucleo-
tide. The purified and fragmented aRNA (12.5mg) was
hybridized to GeneChip Human Genome U133 Plus 2.0
Array (Affymetrix). This system covers over 47000 tran-
scripts from the GenBank, dbEST, and RefSeq database. The
array was incubated for 16h at 451C, then automatically
washed and stained with GeneChip Hybridization, Wash and
Stain Kit (Affymetrix). The hybridized aRNA was detected
with streptavidin-PE. The probe array was scanned using a
GeneChip Scanner 3000 7G (Affymetrix) and quantified
using Affymetrix GeneChip Command Console and Affy-
metrix Expression Console (Affymetrix).
The microarray data of our isolated cells was deposited in
the NCBI Gene Expression Omnibus (http://www.ncbi.
nlm.nih.gov/geo, GEO Series accession no. GSE21095).
Table 2 Sequences for primers and the PCR conditions
Gene Sequence Annealing temperature Cycle number Size
SP-A Forward 50-AGGAGCTCCAAGCCACACT-30 62 40 197
Reverse 50-TTCCTCTGGATTCCTTGGG-30
SP-B Forward 50-TGGGAGCCGATGACCTATG-30 62 40 70
Reverse 50-GCCTCCTTGGCCATCTTGT-30
SP-C Forward 50-ATCGGCTCCACTGGCCTCGT-30 62 40 301
Reverse 50-AGTAGAGCGGCACCTCGCCA-30
AQP5 Forward 50-ACTGGGTTTTCTGGGTAGGG-30 60 40 184
Reverse 50-GTGGTCAGCTCCATGGTCTT-30
Vimentin Forward 50-CCCTCACCTGTGAAGTGGAT-30 60 30 241
Reverse 50-TCCAGCAGCTTCCTGTAGGT-30
a-SMA Forward 50-TTCAATGTCCCAGCCATGTA-30 60 30 222
Reverse 50-GAAGGAATAGCCACGCTCAG-30
Foxf1 Forward 50-ATATCAAGCAGCAGCCCCTGTC-30 50 35 271
Reverse 50-ATGTCTTGGTAGGTGACCTG-30
Tbx4 Forward 50-CACTACCAGCACGAGAAC-30 50 35 163
Reverse 50-CCAGATAGGATCGCTTGC-30
FosB Forward 50-TCCTCACCCTCTGCCGAGTCTCAA-30 60 35 306
Reverse 50-ACTCGCTCCGCCACTGCTGTAG-30
Laminin a5 Forward 50-TGGCTGGATTATGTACTCGTGG-30 54 38 226
Reverse 50-CTGTAGCACCTACTTCGTGGCA-30
DLX5 Forward 50-CTACAACCGCGTCCCAAG-30 52 35 223
Reverse 50-CACCTGTGTTTGTGTCAATCC-30
N-cadherin Forward 50-CACTGCTCAGGACCCAGAT-30 59 35 416
Reverse 50-TAAGCCGAGTGATGGTCC-30
HOXC10 Forward 50-CCGACTCCAGCCCAGACAC-30 54 38 101
Reverse 50-CTTCTTCCTTCCGCTCTTTGC-30
HAS1 Forward 50-GGGCTTGTCAGAGCTACTT-30 60 38 222
Reverse 50-AGGGCGTCTCTGAGTAGCAG-30
b-Actin Forward 50-GCTCGTCGTCGACAACGGCTC-30 55 28 353
Reverse 50-CAAACATGATCTGGGTCATCTTCTC-30
SP-A, surfactant protein-A; SP-B, surfactant protein-B; SP-C, surfactant protein-C; AQP5, aquaporin 5; a-SMA, a-smooth muscle actin; Foxf1, Forkhead box F1;
Tbx4, T-box4; FosB, FBJ murine osteosarcoma viral oncogene homolog B; DLX5, distal-less homeobox 5; HOXC10, homeobox C10; HAS1, hyaluronan synthase1 .
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cells and BM-MSCs, we downloaded the raw data set of
BM-MSCs from the NCBI GEO website (GSE9451). A pre-
vious publication reported that the Affymetrix GeneChip
system allows direct comparison between data sets obtained
in different centers, provided the same chip and the same
normalization are used.
22 Expression measures were com-
puted with GeneSpring GX software version 10.0 (Agilent
Technologies, Santa Clara, CA, USA), using Microarray Suite
version 5.0 (MAS 5.0) algorithm. Genes flagged as ‘present’
or ‘marginal’ call in each batch of the cell populations
were defined as genes expressed in the populations.
The area-proportional Venn diagram was generated using
the BioVenn-web application (http://www.cmbi.ru.nl/cdd/
biovenn/index.php).
23 Calculation of fold change and un-
paired t-test was conducted between our isolated cells and
BM-MSCs using GeneSpring GX software version 10.0
(Agilent). Gene ontology term enrichment was analyzed by
the Functional Annotation Clustering Tool in the Database
for Annotation, Visualization and Integrated Discovery
(version 6.7, DAVID, http://david.abcc.ncifcrf.gov).
24 The
major gene ontology terms associated with each group
are manually summarized based on gene-term enrichment
buttons provided for each functional group.
25
Induction of Differentiation to ATII Cells
To induce differentiation into ATII cells, a human ATII cell
culture system was adopted with some modifications.
26 Cells
(5 10
5) at passage 4 or 5 were plated on cell culture inserts
(BD) that were previously coated with a mixture of 60%
Matrigel (BD) and 40% rat tail collagen I (BD) in DMEM/
5%FBS. After 4h, the media was changed to DMEM con-
taining 5% FBS with 10ng/ml human recombinant kerati-
nocyte growth factor (KGF; PeproTech, Rocky Hill, NJ, USA),
0.1mM 8-bromo cAMP (cAMP; Sigma-Aldrich) and 0.1mM
IBMX (Sigma-Aldrich). The media were changed every other
day and cells were cultured until day 7 when cells were
analyzed.
For hematoxylin–eosin staining, whole cell-embedded
gels were fixed with 10% formalin and embedded with par-
affin. Sections were cut at 3mm thickness and stained with
hematoxylin–eosin. For immunofluorescence staining, whole
gels were directly embedded in OCT compound and frozen
in liquid nitrogen. Cryostat sections (6mm) were fixed with
acetone for 10min at  201C. The blocking procedure and
following steps were performed as previously described. We
used the following antibodies: rabbit anti-human pro-SP-C
(1:1000, Millipore), mouse anti-human CD90 (1:50, BD
Biosciences), Alexa Fluor 647-anti-mouse IgG and Alexa
Fluor 488-anti-rabbit IgG (1:100, Molecular Probes). For
electron microscopic analysis, whole gels were fixed in a
mixture of 2% paraformaldehyde and 2.5% glutaraldehyde
buffered with 0.1M sodium cacodylate (pH 7.2) and post-
fixed in 1% osmium tetroxide. The gels were dehydrated in
ethanol followed by treatment with propylene oxide, and
then embedded in epoxy resin. Sections were stained with
uranyl acetate and lead citrate, and examined with an elec-
tron microscope (Hitachi High-Technologies Corporation
2000, Tokyo, Japan).
Immunofluorescence Staining of Pro-SP-C and CD90
in Human Lung Sections
For histological observations, cryostat sections (6mm) were
fixed with acetone for 10min at  201C. Formalin-fixed,
paraffin-embedded specimens were cut into 3mm sections.
Antigen retrieval solution at pH 9 (Nichirei, Tokyo, Japan)
was used for 5min at 1211C for only formalin-fixed paraffin-
embedded sections. The blocking procedure and following
steps were performed as previously described. However, the
permeabilization step was not necessary. The mouse anti-
human CD90 antibody from Serotec was used for formalin-
fixed paraffin-embedded sections and mouse anti-human
CD90 antibody from BD Biosciences was used for OCT-
compound frozen sections. Confocal images were taken using
a Nikon A1Rsi imaging system (Nikon, Tokyo, Japan).
Statistics
Statistical analyses were performed with GraphPad Prism
Version 5.0b (GraphPad Software). For each parameter
measured, the value for individual samples were averaged
for each experimental group and the s.d. was calculated.
Data were compared using the unpaired t-test. Statistical
significance was defined as Po0.05.
RESULTS
Isolation of a MSC-like Population with Alveolar
Epithelial Phenotypes from Adult Human Lungs
We isolated colony-forming cells from adult human lungs,
using a culture system consisting of feeders (mitotically
inactivated mouse embryonic fibroblasts) that were previously
used for deriving murine lung stem cells.
12,13 We seeded non-
hematopoietic lung cells on feeders. In all specimens, spindle-
shaped cells gave rise to colonies 6–10 days after the start of
culture (Figure 1a). The colony-forming cells proliferated and
reached to the confluency until 4 weeks. The spindle-shaped
cells that formed colonies could be passaged and uniformly
expanded (Figure 1b). Subsequent cultures were performed
without feeders. After more than seven passages, these ex-
panded cells became morphologically broad and flattened,
suggesting that cellular senescence had occurred.
27 Therefore,
we analyzed the cells within 4–6 passages in this study.
The colony-forming cells co-expressed several surface
markers of MSCs and surfactant proteins associated with
ATII cells. The expanded cells at passage 4–6 expressed CD73,
CD90, and CD105, which are defined as positive markers
for human MSCs
28 (Figure 1c). These expanded cells co-
expressed CD90 with low expression of pro-SP-C (Figure 1d).
Immunofluorescence staining confirmed that pro-SP-C and
CD90 were expressed by the expanded cells (Figure 1e, left
panel). Pro-SP-C expression in the expanded cells was weaker
Adult human lung progenitor cells
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panel). At the same time, SP-A and SP-D were expressed by
the expanded cells (Figure 1f and g). These cells were positive
for vimentin (Figure 1h), but negative for E-cadherin (Figure
1c). In addition, these cells did not express markers of tissue
stem cells (c-kit/CD133), hematopoietic cells, or endothelial
cells (CD45/CD34/CD31/VEGF receptor 2) (Figure 1c).
Positive controls for flowcytometric analyses were demon-
strated in Supplementary Figure 1. These data demonstrate
that we isolated an MSC-like cell population with the
expression of surfactant proteins, that are represented as
pro-SP-C
þ/CD90
þ cells, from adult human lungs.
The Pro-SP-C
þ/CD90
þ Cells Show the Clonogenic
Ability and the Mesodermal Differentiation
Capability In Vitro
The pro-SP-C
þ/CD90
þ cells isolated from adult human
lungs shared the same surface markers as BM-MSCs, there-
fore, we investigated whether the pro-SP-C
þ/CD90
þ cells
had the ability of self-renewal and mesodermal differentia-
tion. First, we tested the clonogenic ability of the pro-SP-C
þ/
CD90
þ cells. As shown in Figure 2a, the pro-SP-C
þ/CD90
þ
cells generated secondary colonies from a single cell. To de-
termine the frequency of clonogenic cells in each patient,
limiting dilution analysis was performed. We found that the
Figure 1 Morphology and protein expression of colony-forming cells derived from adult human lungs. Representative images of a colony generated from
CD45
  lung cells (a) and expanded spindle-shaped cells at passage 5 (b). (c) Representative immunophenotypes of the expanded cells at passage 4–6.
These cells expressed mesenchymal stem cell (MSC) markers (CD73, CD90, and CD105) but not known endogenous stem cell markers (c-kit and CD133).
Hematopoietic/endothelial markers (CD45, CD34, CD31, and VEGF receptor 2 (VEGFR2)) were not expressed. E-cadherin (an epithelial marker) was negative.
(d) Flow cytometric analysis of pro-surfactant protein-C (pro-SP-C; an alveolar type II (ATII) cell marker) and CD90 (an MSC marker) in the expanded cells (left
panel) and primary CD45
  lung cells (right panel). The expanded cells from the colony-forming cells expressed CD90 with low expression of pro-SP-C.
Primary CD45
  lung cells were used for controls of pro-SP-C and CD90 staining. (e) Immunofluorescence staining of pro-SP-C (green) and CD90 (red) in the
expanded cells (left panel) and CD45
  lung cells (right panel). The expanded cells cultured on a chamber slide were fixed and stained. Primary CD45
  lung
cells were cytospun for immunostaining. ATII cells expressed pro-SP-C, but not CD90 (arrow). Arrowhead indicates cells expressing CD90 alone. Insets show
isotype controls. (f–h) Immunofluorescence staining for SP-A (f; an ATII cell marker; green), SP-D (g; an ATII cell marker; green) and vimentin (h;a
mesenchymal marker; green) in the expanded cells that were cytospun. Flow cytometric analyses and immunofluorescence staining were performed
for samples from three different patients. Scale bars: (a, b) 200mm; (e)5 0mm; (f–h)1 0mm.
Adult human lung progenitor cells
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17.1±9.2% (mean±s.d., n¼6; Figure 2b). To purify clo-
nogenic cells, we sorted single cells out of the pro-SP-C
þ/
CD90
þ cells. The expanded clonogenic cells expressed CD73,
CD90, CD105, and pro-SP-C at a proportion similar to that
of the pre-sorted population (Figure 2c). In addition, these
clonogenic cells co-expressed pro-SP-C and CD90 by im-
munostaining (Supplementary Figure 2), and SP-A and SP-D
were also expressed (data not shown). RT–PCR showed that
mRNA of SP-B, SP-C, vimentin, and a-smooth muscle actin
(a-SMA) was expressed in these clonogenic cells as well as
pre-sorted cells (Figure 2d). These data suggest that the pro-
SP-C
þ/CD90
þ cells had the clonogenic ability. Second, we
examined whether the pro-SP-C
þ/CD90
þ cells could dif-
ferentiate into adipocytes, osteoblasts, and chondrocytes. In
adipogenic differentiation, the pro-SP-C
þ/CD90
þ cells dif-
ferentiated into adipocytes that expressed FABP4 as shown by
immunostaining and these differentiated cells contained lipid
droplets as demonstrated by oil red O staining (Figure 2e).
In osteogenic differentiation, the pro-SP-C
þ/CD90
þ cells
differentiated into osteoblasts that expressed osteocalcin as
shown by immunostaining and these differentiated cells de-
veloped calcification as demonstrated by Arizarin S staining
(Figure 2e). However, even after pellets of the cells were
stimulated with transforming growth factor-b3 during
chondrogenic differentiation, aggrecan, which is a specific
marker for chondrocytes, was not expressed in the pellets as
demonstrated by immunostaining (data not shown). These
data demonstrate that the pro-SP-C
þ/CD90
þ cells that we
isolated from adult human lungs have a limited differentia-
tion capability toward mesenchymal lineages.
Comparison of Transcription Profiles Between
Pro-SP-C
þ/CD90
þ Cells and BM-MSCs
To compare transcription profiles between pro-SP-C
þ/
CD90
þ cells and BM-MSCs, RNA isolated from three bat-
ches of the pro-SP-C
þ/CD90
þ cells from different subjects
was analyzed with the Affymetrix array. We directly down-
loaded the raw data set of the transcription profiles of BM-
MSCs from the GEO website (GSE9451). The self-renewal
ability, multipotency, and genetic signatures of the BM-MSCs
were well characterized according to a previous report.
29 We
found that 11131 genes (21560 probes) were expressed by all
of three batches of the pro-SP-C
þ/CD90
þ cells and 10812
genes (20512 probes) were expressed by all of three batches
of the BM-MSCs. The Venn diagram demonstrated that 1909
genes (3037 probes) were specifically expressed by the pro-
SP-C
þ/CD90
þ cells and 1325 genes (1989 probes) were
Figure 1 Continued.
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form gene ontology term enrichment analysis in each gene set
that was specifically expressed by pro-SP-C
þ/CD90
þ cells or
BM-MSCs, we utilized the web-based database (DAVID version
6.7, http://david.abcc.ncifcrf.gov).
24 Functional annotation
clustering in DAVID revealed that genes associated with
transcription and lung development were enriched in
pro-SP-C
þ/CD90
þ cells, while genes associated with skeletal
Adult human lung progenitor cells
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þ/CD90
þ cells have the ability of self-renew and mesodermal differentiation. (a) Representative images of proliferating cells and a secondary
colony from a single cell. (b) Frequency of clonogenic cells in each patient. Limiting dilution analysis revealed that the minimum frequency of clonogenic cells in
each patient was 17.1±9.2% (mean±s.d., n¼6). The mean and s.d. of the frequencies are shown as crossbars. (c) Flow cytometric analyses for CD73, CD90, CD105,
and pro-SP-C in pre-sorted cells (pre-sorted) and clonogenic cells (clone). Isotype controls were shown in gray. (d) Semiquantitative RT–PCR for SP-B, SP-C, vimentin,
and a-smooth muscle actin (a-SMA) in pre-sorted cells and two batches of clonogenic cells (clones 1 and 2). Whole lung is used for positive control (lung) and RNA
sample from whole lung without reverse transcriptase reaction is used for negative control (no-RT). (e) Representative images of adipogenic and osteogenic
differentiation of the pro-SP-C
þ/CD90
þ cells. Fatty acid binding protein 4 (FABP4)-positive cells indicated mature adipocytes (left upper panel, orange) and oil red O
staining showed lipid deposition (right upper panel, red) in adipogenic differentiation. Osteocalcin-positive cells were osteoblasts (left lower panel, red) and alizarin S
staining demonstrated calcium deposition (right lower panel, red) in osteogenic differentiation. Scale bars: (a)1 0 0mma n d( e)5 0mm.
Figure 3 Comparison of transcription profiles between pro-SP-C
þ/CD90
þ cells and bone marrow-mesenchymal stem cells (BM-MSCs). (a) The area-proportional
Venn diagram presenting the overlap between transcripts expressed in pro-SP-C
þ/CD90
þ cells (blue) and BM-MSCs (red). (b) Functional annotation clustering in
specifically expressed gene sets in pro-SP-C
þ/CD90
þ cells (blue) or BM-MSCs (red). Original array data are available at http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?token¼zpapfyaqumsqmvw&acc¼GSE21095. (c) Semiquantitative RT–PCR for eight genes identified through the microarray analysis. Forkhead box f1
(Foxf1), T-box 4 (Tbx4), FBJ murine osteosarcoma viral oncogene homolog B (FosB), and laminin a5, that were selected out of the annotations of ‘transcription’ and/
or ‘lung development’, were highly expressed by pro-SP-C
þ/CD90
þ cells. At the same time, distal-less homeobox 5 (DLX5), N-cadherin, homeobox C10 (HOXC10),
and hyaluronan synthase 1 (HAS1), that were chosen from the annotation of ‘skeletal system development’ or ‘cell adhesion’, were highly expressed by BM-MSCs.
Three bathes of pro-SP-C
þ/CD90
þ cells and three batches of BM-MSCs were examined. b- A c t i nw a su s e da sa ne n d o g e n o u sc o n t r o l .I nR T – P C Rf o rF o x f 1 ,T b x 4 ,
FosB, laminin a5, and b-actin, a representative negative control (pro-SP-C
þ/CD90
þ cells batch1 without reverse transcriptase reaction) is shown as no-RT. In RT–PCR
for DLX5, N-cadherin, HOXC10, and HAS1, a representative negative control (BM-MSCs batch1 without reverse transcriptase reaction) is shown as no-RT.
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enriched in BM-MSCs (Figure 3b). We confirmed the
expression of genes identified through the microarray analysis
using RT–PCR. We selected four genes specifically expressed
by pro-SP-C
þ/CD90
þ cells, including Forkhead box f1
(Foxf1), T-box 4 (Tbx4), FBJ murine osteosarcoma viral
oncogene homolog B (FosB) and laminin a5. At the same
time, we evaluated mRNA expression of four genes specifically
expressed by BM-MSCs, including distal-less homeobox 5
(DLX5), N-cadherin, homeobox C10 (HOXC10), and hyalur-
onan synthase 1 (HAS1). Figure 3c showed that the expression
of Foxf1, Tbx4, FosB, and laminin a5 was upregulated
in pro-SP-C
þ/CD90
þ cells, while DLX5, N-cadherin,
HOXC10, and HAS1 were exclusively expressed by BM-MSCs.
SP-C mRNA was not expressed in BM-MSCs (data not
shown).
Figure 4 The pro-SP-C
þ/CD90
þ cells differentiate into ATII cells in vitro.( a–f) Representative morphologic appearances of cells cultured on a mixture
of Matrigel and rat tail collagen with keratinocyte growth factor (KGF), cAMP, and IBMX (KIA(þ), left side panels) and without any additives (KIA( ), right
side panels) in phase contrast images (a, b) and hematoxylin–eosin (HE) staining (c, d) and immunofluorescence staining of pro-SP-C (green) and CD90
(red) (e, f). White arrowheads indicate pro-SP-C
þ/CD90
  cells (ATII cells) and white arrows show SP-C
 /CD90
þ cells (e, f). A pro-SP-C
þ/CD90
þ cell
was still observed (yellow arrowhead in e). Unidentified differentiated cells expressing neither pro-SP-C nor CD90 were seen (yellow arrows in e, f).
(g, h) Transmission electron microscopic images of differentiated cells in KIA(þ) group. (g) Lamellar bodies (a white-framed rectangle) and apical microvilli
(arrows) were observed as distinctive structures in ATII cells. (h) A higher magnification of lamellar bodies from a white-framed rectangle in (g). (i) The ratio
of the number pro-SP-C
þ/CD90
  cells to the number of DAPI-stained nuclei was significantly higher in the KIA(þ) group than that in the KIA( ) group
(47.8±12.2% vs 2.5±2.5%, n¼4 in each, P¼0.0003). (j) Representative RT–PCR analysis of SP-A, SP-C (ATII cell markers) and aquaporin 5 (AQP5; an ATI
cell marker) and vimentin and a-SMA (mesenchymal markers) before and after differentiation. Scale bars: (a, b) 200mm; (c, d)5 0mm; (e, f)2 0mm; (g)2mm;
(h) 300nm.
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þ/CD90
þ
Cells In Vitro
To investigate whether the pro-SP-C
þ/CD90
þ cells could
differentiate into ATII cells in vitro, we cultured these cells on
a mixture of Matrigel and collagen type I gel in the presence
of KGF, cAMP, and IBMX, a modified version of the culture
system used by Wang et al.
26 In every specimen exposed to
KGF, cAMP, and IBMX (KIA(þ) group), differentiated
cells possessed an epithelial cell-like appearance on the gel
(Figure 4a). Upon hematoxylin–eosin staining, these differ-
entiated cells formed a monolayer and had a cuboidal shape
that resembled the morphology of ATII cells (Figure 4c).
Immunofluorescence staining showed that the cuboidal-
shaped cells expressed pro-SP-C but not CD90 (Figure 4e),
although almost all cells before differentiation expressed
CD90 (Figure 1c). In addition, these differentiated cells ex-
pressed SP-A and SP-D (data not shown). Transmission
electron microscopy indicated that cuboidal cells displayed
lamellar bodies and apical microvilli, which are distinctive
structures of ATII cells
30 (Figure 4g and h). By contrast, cells
cultured without any additives on Matrigel/collagen gels
(KIA( ) group) showed an elongated shape and formed
multiple layers (Figure 4b and d). Multilayered and flattened
cells in the KIA( ) group remained positive for CD90, but
lost SP-C expression (Figure 4f). To quantify ATII cell
differentiation, we counted the number of pro-SP-C-positive
and CD90-negative cells (ATII-like cells) as a ratio of the
total population (the number of DAPI-stained nuclei).
We found that the ratio of the number of pro-SP-C
þ/CD90
 
cells to the number of DAPI-stained nuclei in the KIA(þ)
Figure 4 Continued.
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was 2.5±2.5% (n¼4 in each; P¼0.0003; Figure 4i). In
addition, semiquantitative RT–PCR confirmed that the
expression of mRNA of SP-A and SP-C was upregulated and
the expression of mRNA of vimentin and a-SMA decreased
in the KIA(þ) group (Figure 4j). The expression of mRNA
of AQP5 (an ATI cell marker) was upregulated both in
the KIA(þ) group and in the KIA( ) group (Figure 4j). The
expression of mRNA of SP-A and SP-C in the KIA( ) group
was not upregulated (Figure 4j).
Localization of Pro-SP-C
þ/CD90
þ Cells in Normal
Lungs, Lung Fibrosis, and Lung Adenocarcinoma
Thus far, the pro-SP-C
þ/CD90
þ cells that we isolated from
adult human lungs were derived after an extended period
of culture. Therefore, we sought to investigate whether cells
with similar characteristics exist in situ in human lungs. In
normal lung tissues, pro-SP-C
þ/CD90
þ cells located within
alveolar walls (Figure 5a and b). However, we could not find
any pro-SP-C
þ/CD90
þ cells in the bronchi, bronchioles,
bronchioalveolar duct junctions, interlobular septa, blood
Figure 5 Localization of pro-SP-C
þ/CD90
þ cells in normal lung (a, b) and damaged lung (c–f). (a) Immunofluorescence staining for pro-SP-C (green) and
CD90 (red) in normal alveoli. Arrowhead shows a pro-SP-C
þ/CD90
þ cell. The pro-SP-C
 /CD90
þ cell was a pericyte in the alveolar wall (arrow).
47,48 (b)A
confocal image from a white-framed rectangle in (a). (c, e) Low magnified images from the lung tissues from a patient with idiopathic pulmonary fibrosis
(IPF). (c, e) are serial sectioned images. V, pulmonary vein. (c) HE staining showed that patchy fibrosis with remodeling of lung structure in a subpleura
region. (e) Immunofluorescence staining for pro-SP-C (green) and CD90 (red) in specimen correlating to the area in (c). Positive immunostaining for CD90
(red, arrows) was observed in the wall of vascular structures (V), as previously reported.
49 (d, f) Higher magnification of hyperplasia of ATII cells from the
boxes in (c, e). Double-positive cells (arrowheads) for pro-SP-C (green) and CD90 (red) were seen within ATII cell hyperplasia that are thought to contribute
to alveolar epithelial regeneration.
11 ATII cells (arrows) are located around the pro-SP-C
þ/CD90
þ cells. (g) The ratio of pro-SP-C
þ/CD90
þ cells to CD45
 
lung cells significantly increased in fibrotic lungs (1.23±0.13%, n¼3) compared with normal lungs (0.32±0.06%, n¼3, P¼0.0003). Data show mean±s.d.
Scale bars: (a)5 0mm; (b)1 0mm; (c, e) 200mm; (d, f)5 0mm.
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C
þ/CD90
þ cells in damaged lungs, we performed im-
munofluorescence staining in lung sections from patients
with idiopathic pulmonary fibrosis. Pro-SP-C
þ/CD90
þ cells
were localized and proliferative in hyperplasia of ATII
cells, which is thought to be regenerative epithelium
11
(Figure 5c–e). Flow cytometric analysis demonstrated that
the ratio of pro-SP-C
þ/CD90
þ cells to CD45
  lung cells
was significantly higher in fibrotic lungs than in normal
lungs (1.23±0.13% vs 0.32±0.06%, mean±s.d., n¼3,
P¼0.0003). To determine whether pro-SP-C
þ/CD90
þ cells
were involved in lung adenocarcinoma, we performed im-
munostaining in sections derived from lung adenocarcino-
mas. A subset of lung adenocarcinomas expressed both
pro-SP-C and CD90 (Figure 6).
DISCUSSION
In this study, we isolated progenitor cells with the ability to
differentiate into ATII cells from adult human lung. We
found that clonogenic cells isolated from adult human lungs
expressed MSC markers combined with ATII cell-related
protein expression (pro-SP-C). This cell population gener-
ated ATII cells upon differentiation-inducing stimuli in vitro.
Hereafter, we refer to our isolated pro-SP-C
þ/CD90
þ cells
as alveolar epithelial type II progenitor cells (AEPCs).
AEPCs derived from adult human lungs had the clono-
genic ability (Figure 2a and b). This ability of clonal
expansion is one of the most essential qualifications for
defining progenitor cells.
12,21,31,32 Flow cytometric analysis
and immunofluorescence staining indicated that the un-
differentiated AEPCs have already been committed to an ATII
cell lineage. Indeed the undifferentiated AEPCs express both
mRNA and surfactant proteins of SP-A, SP-B, pro-SP-C, and
SP-D (Figures 1c–f and 2d). This feature is consistent with a
previous report that adult liver progenitor cells possess un-
differentiated signatures with commitment of a hepatocyte
lineage.
33 We demonstrated the capability that AEPCs gen-
erate ATII cells by several methods. First, AEPCs differ-
entiated by extracellular matrix with KGF, cAMP, and IBMX
exhibited cuboidal-shaped morphologies with lamellar bod-
ies in histological examinations (Figure 4a, c, g, and h).
Second, differentiated AEPCs strongly expressed surfactant
proteins but were not immunopositive for CD90 (Figure 4e
and i). In addition, RT–PCR confirmed that the expression
of alveolar epithelial markers (SP-A, SP-C, and AQP5)
was upregulated and mesenchymal markers (vimentin and
a-SMA) was downregulated in differentiated AEPCs
(Figure 4j).
AEPCs possess similar characteristics to BM-MSCs, but
differ in the ability of chondrogenic differentiation and the
Figure 5 Continued.
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MSCs were previously reported.
28 In accordance with these
criteria, the expression of MSC markers (CD73, CD90, and
CD105) and the ability to differentiate into adipocytes and
osteocytes demonstrated that AEPCs share phenotypes with
MSCs (Figures 1c, 2c and e). However, we could not readily
induce differentiation of AEPCs into a chondrogenic lineage
under the standard culture condition used in a typical
chondrogenic differentiation assay. In addition, unlike
BM-MSCs, our microarray analyses and RT–PCR (Figure 3)
indicated that AEPCs specifically expressed key genes en-
coding transcription factors or extracellular matrix associated
with lung development, including Foxf1,
34 Tbx4,
35 FosB,
36
and laminin a5.
37 At the same time, AEPCs had little or no
expression of crucial genes determining the phenotypes of
BM-MSCs and associated with skeletal morphogenesis like
DLX5,
38 N-cadherin,
39 HOXC10,
40 and HAS1.
41 Bronch-
oalveolar lavage (BAL)-derived MSCs expressed DLX5 and
N-cadherin with the same level as BM-MSCs.
19 Although, it
is difficult to simply compare the expression of DLX5 and
N-cadherin between our isolated AEPCs and BAL-derived
MSCs, the partially shared phenotypes of AEPCs with
BM-MSCs propose some ideas that AEPCs may differ from
BAL-derived MSCs or AEPCs may be included in a subset of
the lung MSCs.
Epithelial–mesenchymal transition and its opposite me-
chanism, mesenchymal–epithelial transition, have key roles
in early embryonic morphogenesis, cancer stem cells, and
cancer metastasis.
42–44 Acquisition of a mesenchymal phe-
notype gives cells motility and invasive capability.
44 AEPCs
expressed vimentin but not E-cadherin (Figure 1c and h). In
addition, AEPCs expressed mRNA of Foxf1 and Tbx4, whose
expression is restricted to mesenchymal cells during lung
development.
45 These data suggested that AEPCs are derived
from lung mesenchyme rather than epithelium. The transi-
tional phenotypes between the mesenchyme and epithelium
observed in AEPCs suggest that these cells act as lung tissue
progenitor cells in tissue repair and carcinogenesis. To
be involved in alveolar repair, mesenchymal properties such
as anti-apoptotic activity and motility may be beneficial for
functional progenitor cells.
We demonstrated that pro-SP-C
þ/CD90
þ cells, which
express the same markers as our isolated AEPCs, proliferated
within ATII cell hyperplasias in idiopathic pulmonary fibrosis
lungs and in a subset of lung adenocarcinomas (Figures 5c–g
and 6). Positive staining of CD90 in proliferative epithelial
cells in fibrotic lungs is compatible with a previous report.
46
Hyperplasia of ATII cells is considered to be involved in al-
veolar epithelial repair in response to injury.
7–11,30 Our data
and these previous reports suggest AEPCs possibly partici-
pate in lung fibrosis. However, a pathophysiological role of
AEPCs in disease development is not yet clear. Therefore, it is
possible that the pro-SP-C
þ/CD90
þ hyperplasia and the
pro-SP-C
þ/CD90
þ cancer cells were due to the resultant of
the disease progression. Further studies are needed.
We could not demonstrate a precise hierarchy between
AEPCs, ATII cells, and ATI cells. According to our in vitro
cellular assays and in situ histopathological evaluation,
AEPCs have a potential role as precursors of ATII cells.
However, the possibility of direct differentiation from AEPCs
into ATI cells cannot be excluded because the expression
AQP5, an ATI cell marker, increased even without upregu-
lation of SP-C expression in the differentiation assay
(Figure 4i). This result is compatible with a previous report
20
and suggests that AEPCs differentiate directly into ATI cells
not through ATII cells. Further studies will be necessary
to establish the hierarchy among AEPCs, ATII cells, and
ATI cells.
In conclusion, to our knowledge, this study is the first to
report that ATII progenitors exist in adult human lungs.
Impaired proliferation and differentiation, or cell senescence,
in AEPCs may have an important role in the pathogenesis of
severe lung diseases. Therefore, AEPCs may be a good target
for drug discovery and screening.
Supplementary Information accompanies the paper on the Laboratory
Investigation website (http://www.laboratoryinvestigation.org)
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